{"tm":1686889498,"s":"EDIT","news":[{"t":"Editas Medicine Announces Offering of Common Stock","dt":"Jun-14-23 04:05PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-announces-offering-common-200500733.html"},{"t":"Editas (EDIT) Posts Upbeat Initial Data From SCD &amp; TDT Studies","dt":"Jun-12-23 10:00AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/editas-edit-posts-upbeat-initial-140000887.html"},{"t":"Why Is Emergent Biosolutions (EBS) Down 21.4% Since Last Earnings Report?","dt":"Jun-08-23 11:30AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/why-emergent-biosolutions-ebs-down-153056075.html"},{"t":"Editas Medicine Reports Inducement Grant to New Chief Financial Officer","dt":"May-18-23 04:30PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-reports-inducement-grant-203000717.html"},{"t":"Industry Analysts Just Upgraded Their Editas Medicine, Inc. (NASDAQ:EDIT) Revenue Forecasts By 14%","dt":"May-10-23 06:02AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/industry-analysts-just-upgraded-editas-100203559.html"},{"t":"Editas Medicine First Quarter 2023 Earnings: Beats Expectations","dt":"May-06-23 08:14AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-first-quarter-2023-121428979.html"},{"t":"Editas Medicine Announces Publication in Nature Biotechnology of Comprehensive SLEEK Gene Editing Technology Data","dt":"May-01-23 04:01PM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-announces-publication-nature-200100816.html"},{"t":"Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?","dt":"Apr-27-23 10:03AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/codexis-cdxs-expected-beat-earnings-140302786.html"},{"t":"Earnings Preview: Editas Medicine (EDIT) Q1 Earnings Expected to Decline","dt":"10:02AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/earnings-preview-editas-medicine-edit-140202585.html"},{"t":"2 Stocks Under $15 Per Share to Consider","dt":"Apr-16-23 09:00AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/f0722dbe-27cb-3751-ac4a-e8ac916ceee9\/2-stocks-under-%2415-per-share.html"},{"t":"Proceed With Caution When Considering These 5 Ultra-Popular Stocks","dt":"05:25AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/10fa506a-decb-31fe-a1d9-f94f8b26eaa6\/proceed-with-caution-when.html"},{"t":"2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It","dt":"Mar-30-23 08:45AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/09493797-03b3-3950-b782-8d0457c304a2\/2-reasons-to-sell-editas.html"},{"t":"Is Editas Medicine (NASDAQ:EDIT) In A Good Position To Invest In Growth?","dt":"Mar-27-23 06:19AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-nasdaq-edit-good-101959953.html"},{"t":"Editas Medicine Strengthens Executive Leadership Team with Appointment of Linea Aspesi as Chief People Officer","dt":"Mar-08-23 09:00AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-strengthens-executive-leadership-140000117.html"},{"t":"Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates","dt":"Feb-22-23 07:35AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-edit-reports-q4-123512107.html"},{"t":"Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?","dt":"Feb-16-23 11:00AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/9e10dea5-ff4c-3d36-a70d-8cd5b210af8b\/is-exact-sciences-or-editas.html"},{"t":"Are Medical Stocks Lagging  Editas Medicine (EDIT) This Year?","dt":"Feb-14-23 09:40AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/medical-stocks-lagging-editas-medicine-144002404.html"},{"t":"3 No-Brainer Stocks to Buy Right Now for Less Than $25","dt":"Feb-04-23 09:40AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/4af7acec-74ca-3a33-aa9c-f4eccb40390a\/3-no-brainer-stocks-to-buy.html"},{"t":"How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings","dt":"09:00AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/boost-portfolio-top-medical-stocks-140002505.html"},{"t":"Why Editas Medicine Stock Charged Higher in January","dt":"11:33AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/c1002e23-f769-3bda-91d6-6aec99b0e7b0\/why-editas-medicine-stock.html"},{"t":"Editas Medicine (EDIT) Crossed Above the 50-Day Moving Average: What That Means for Investors","dt":"09:30AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-edit-crossed-above-143002648.html"},{"t":"Wall Street Analysts Predict a 72.25% Upside in Editas (EDIT): Here's  What You Should Know","dt":"Jan-25-23 09:55AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/wall-street-analysts-predict-72-145502599.html"},{"t":"Shoreline Biosciences Acquires Editas' iNK Cell Franchise, Related Gene Editing Technologies","dt":"Jan-19-23 09:35AM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/shoreline-biosciences-acquires-editas-ink-143530832.html"},{"t":"Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer &amp; More","dt":"Jan-11-23 11:10AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/biotech-stock-roundup-regn-down-161004459.html"},{"t":"Why Editas Medicine Stock Is Sliding Today","dt":"11:59AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/25e76e5b-5b58-309d-9fa2-b0763cad679a\/why-editas-medicine-stock-is.html"},{"t":"Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference","dt":"Jan-04-23 06:30AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-present-41st-annual-113000601.html"},{"t":"Editas shares jump 9% on positive news from sickle-cell study","dt":"08:00AM","a":"MarketWatch","u":"https:\/\/finance.yahoo.com\/m\/0ac72459-5af2-35b3-9845-6741d3c1214a\/editas-shares-jump-9%25-on.html"},{"t":"Editas (EDIT) Down 13.8% Since Last Earnings Report: Can It Rebound?","dt":"Dec-02-22 11:31AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/editas-edit-down-13-8-163104141.html"},{"t":"Editas (EDIT) Declines More Than 30% in 3 Months: Here's Why","dt":"Nov-28-22 01:08PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/editas-edit-declines-more-30-180806930.html"},{"t":"Gene Editing Stock's Prospects Cut In Half By Analyst, Citing Limited Value In Retina Treatment","dt":"Nov-18-22 02:51PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/gene-editing-stocks-prospects-cut-195152539.html"},{"t":"Citing Small Population, Editas Medicine Pauses Work On Gene Therapy Trial For Genetic Eye Disorder","dt":"01:01PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/citing-small-population-editas-medicine-180100647.html"},{"t":"These Analysts Think Editas Medicine, Inc.'s (NASDAQ:EDIT) Sales Are Under Threat","dt":"Nov-04-22 06:16AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/analysts-think-editas-medicine-inc-101656274.html"},{"t":"Editas Medicine Announces Third Quarter 2022 Results and Business Updates","dt":"06:30AM","a":"GlobeNewswire","u":"https:\/\/finance.yahoo.com\/news\/editas-medicine-announces-third-quarter-103000731.html"}]}